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Abstract
The nucleus pulposus (NP) of the intervertebral disc plays a critical role in distributing mechanical loads to the axial
skeleton. Alterations in NP cells and, consequently, NP matrix are some of the earliest changes in the development
of disc degeneration. Previous studies demonstrated a role for laminin-presenting biomaterials in promoting a healthy
phenotype for human NP cells from degenerated tissue. Here we investigate the use of laminin-mimetic peptides
presented individually or in combination on a poly(ethylene) glycol hydrogel as a platform to modulate the behaviors of
degenerative human NP cells. Data confirm that NP cells attach to select laminin-mimetic peptides that results in cell
signaling downstream of integrin and syndecan binding. Furthermore, the peptide-functionalized hydrogels demonstrate
an ability to promote cell behaviors that mimic that of full-length laminins. These results identify a set of peptides that
can be used to regulate NP cell behaviors toward a regenerative engineering strategy.
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Introduction
Low back pain is a leading cause of years lived with disability (affecting ~80%–90% of people worldwide), and
together with degenerative conditions of the intervertebral
disc (IVD), represents a global socioeconomic and medical burden.1–3 The IVD is located between adjacent vertebrae in the spinal column and is made up of the nucleus
pulposus (NP), anulus fibrosus, and cartilaginous endplates.4,5 These structures collectively distribute mechanical forces applied to the axial skeleton during activities of
daily living and contribute flexibility to the spine.6–11 The
degenerative cascade in the IVD is thought to initiate in
the NP structure with changes including tissue dehydration
and stiffening and a subsequent loss of disc height.1,4,12,13
Patients who present clinically with these changes may
also experience impaired physical function, pain upon
motion, and associated disability.1,14,15
When in a healthy, “juvenile” state, the NP is avascular
and aneural and contains cells derived from the notochord

embedded in a soft (~0.5–1 kPa), highly hydrated (~90%
water by wet weight) matrix.16–20 This extracellular matrix
contains proteoglycans (including aggrecan), collagens
(largely type II), and laminins, amongst other proteins.11,17,21–23 Aging and degeneration, however, result in
altered extracellular matrix biosynthesis for cells of the NP
including increased collagen type I and reduced aggrecan
production; the relative loss of proteoglycan results in
decreased water content and a stiffening of the matrix (10–
20 kPa).18,19,21,24–27 The NP cells also undergo changes with
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maturation and shift from an anabolic, notochord-like phenotype (characterized by large, circular, vacuolated cells in
robust clusters) to an altered state in which the cells assume
an elongated cell shape, lose their vacuoles, and have
reduced biosynthetic capacities.11,17,18,25,26,28 As the NP has
a limited intrinsic ability for self-repair, these alterations
contribute to a feedforward degenerative cascade that
results in progressive damage to the IVD across length
scales, motivating an interest in regenerative engineering
approaches for NP and IVD repair.7,15,24,25
Biomaterial and tissue engineering strategies for the
IVD have been sought as a method to restore characteristics of the native tissues’ structure and function.29,30 A large
body of work has demonstrated an ability to functionalize
polymers with bio-adhesive ligands which are often either
full-length extracellular matrix proteins, or else, small
peptide sequences derived from a constituent of the extracellular matrix.31–37 These approaches offer the opportunity to engineer bioactive materials that promote cell
attachment and modulate cell behaviors.29,38 While fulllength proteins and short peptides have both been utilized
for this purpose, the incorporation of peptides in biomaterial design has several advantages over full-length proteins
- short peptides possess increased stability and can be
more economic.39,40 Additionally, small peptide sequences
offer the ability to provide controlled sites of biomaterialcell interactions.39,40
Laminins are a compositionally minor component of
the IVD extracellular matrix that have been shown to play
important roles in facilitating cell attachment and mechanotransduction by interacting with cells through cell-membrane receptors including integrins and syndecans.41–43 NP
cell interactions with soft (<1 kPa) biomaterials functionalized with full-length laminin proteins have been shown
to promote cell attachment, cell clustering, increased biosynthesis of sulfated glycosaminoglycans, and increased
expression of NP cell markers including integrin α3 and
cytokeratin 8.44,45 Whereas, similarly soft biomaterials that
were either unfunctionalized or conjugated with collagen
type II did not elicit these same responses.44,45 Together
these findings demonstrate that NP cells recognize cues
from the laminin and modulate cellular behaviors in
response. Full-length laminin proteins, however, contain
hundreds of identified bioactive amino acid sequences
across the α, β, and γ chains33,46 which can contribute to
uncontrolled cellular interactions. Studies conducted over
the past several decades have begun to elucidate the adhesive capabilities of laminin-mimetic peptides (LMPs),
their role in promoting cell spreading or other cell behaviors, and the cell surface receptors that recognize each seq
uence.33,47–53 There is therefore an opportunity to use
targeted LMPs to mimic the function of full-length
laminins in biomaterial design for IVD regeneration.
In prior work, select LMPs (from the globular domain
of the α laminin chain including AG73, IKVAV, AG10,
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and GD-6) were conjugated to polyacrylamide and
screened for an ability to promote behaviors consistent
with healthy NP cells – cell attachment, production of sulfated glycosaminoglycans (sGAGs), and expression of
aggrecan, N-cadherin, GLUT1, and collagen I/II mRNA.40
In follow-on work, we recently developed an LMPfunctionalized biomaterial using a poly(ethylene) glycol
(PEG) backbone.54 PEG was chosen from amongst other
hydrogel systems commonly used for NP repair29,55,56 as it
is clinically relevant,57,58 offers independent control of
substrate stiffness and peptide density,54 and allows for the
bioactive component of the hydrogel to be controlled
solely by the ligands functionalized to it.29,45,54 While gels
made of 4% PEG (0.3–0.6 kPa) approximate the stiffness
of the healthy human NP ECM16,19,24 and have demonstrated an ability to promote de-differentiation in degenerative NP cells,45,54,59 stiff gels may have advantages for
clinical use including improved handling properties and
better integration with the native ECM.60,61 Characterization
of human NP cell attachment, morphology, cytoskeletal
organization, and protein/gene expression profiles revealed
an ability for stiff (15% PEG, 10.5 kPa) gels functionalized
with 100 µM of peptide (50 µM AG73 in combination with
50 µM IKVAV) to recapitulate behaviors seen on soft PEG
gels functionalized with full-length laminin (LM-111).54
This finding corroborates that stiffness alone is not the
master variable controlling the NP cell phenotype, and that
peptide density and sequence are important variables in
designing a bioactive, clinically relevant, material for NP
cell support.
In the present study, a library of biomaterials was synthesized using the peptide-functionalized PEG hydrogel
strategy to support development of biomaterials that present a range of LMPs in order to regulate NP cell behaviors. An initial list of candidate peptides from laminin
isoforms present in the NP ECM21,23,37,62,63 was created and
narrowed based on the reported ability of the peptide
sequences to support cell attachment and in keeping with
the cell surface receptors believed to mediate attachment
for NP cells. The integrin-binding LMPs (YIGSR, P4,
A5G81, GD-6, and IKVAV) used herein (Figure 1) were
chosen based on prior literature which has validated their
ability to promote attachment of NP cells or other cell
types through integrins including α3 and α6,40,54,64–68 proteins known to be expressed in NP cells.41,42 The syndecanbinding peptide AG73 was also chosen for evaluation
based on prior work suggesting that AG73 can facilitate
NP cell attachment.40,54 The objective of this work was to
evaluate the effects of presenting integrin-binding and
syndecan-binding peptides individually or in combination
upon the peptide-functionalized PEG hydrogels as measured by the ability of the biomaterial to promote NP cell
attachment, modulate cell morphology, engage mechanosensitive signaling pathways, and regulate protein/gene
expression.
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Figure 1. Laminin-mimetic peptides used to functionalize PEG hydrogels. (Left) Table of peptides, amino acid sequence, location
on laminin protein, and putative cell surface receptors. (Right) Location of peptide sequences on the laminin protein, created with
BioRender.com.
blue: syndecan-binding peptide; red: integrin-binding peptides.

Methods and materials
Primary human NP cell culture
NP tissue was obtained from to-be-discarded surgical
waste tissues of anonymized patients (only sex, age and
race were recorded; ages 16–75, male and female) receiving surgical treatment for degenerative conditions of the
IVD. NP cells were enzymatically isolated from tissues as
previously described.54,69,70 Briefly, NP tissue was digested
at 37°C for 2–4 h (0.2% pronase (Roche; Basel,
Switzerland), 0.4% collagenase type II (Worthington
Biochemical; Lakewood, NJ), and 5% Fetal Bovine Serum
(FBS); 23 ml per gram tissue). The resulting solution was
passed through a 70 µm filter in order to isolate the NP
cells which were then expanded in monolayer culture
using Ham’s F12 media (Life Technologies; Carlsbad,
CA) supplemented with 1% penicillin/streptomycin and
10% FBS under 5% CO2 and atmospheric O2 at 37°C.
Expanded cells were used for experimentation at passages
0–4; all experiments made use of multiple samples (biological replicates) from at least three human subjects with
assay-specific sample sizes as detailed below.

Formation of hydrogels
Laminin-mimetic Peptide (LMP) Hydrogels 15% PEG
hydrogels (% w/v; ~10.5 kPa) were formulated as previously described.54 Briefly, 8-arm star PEG terminated with
maleimide (PEG-8MAL, MW 20 kDa) and PEG-dithiol
(SH-PEG-SH, MW 600 Da) were obtained from Creative
PEGWorks (Durham, NC). Cysteine-terminated lyophilized
peptides (YIGSR, P4, A5G81, GD-6, IKVAV, and AG73;
sequences listed in Figure 1, GenScript Biotech, Piscataway,
NJ) and PEG-MAL were each dissolved in 1X PBS (pH
3.25; acidic conditions were used to control reaction
speed54,71) and combined to achieve a final total peptide
concentration of 100 µM and functionalization of the PEG
backbone through a maleimide-thiol Michael-type addition
reaction. Gels were functionalized with a single peptide

(100 µM) or with two peptides (dual peptide; 50 µM of each
to achieve a total of 100 µM). Separately, PEG-dithiol was
also dissolved in 1X PBS pH 3.25. To form gels (at room
temperature), the PEG-dithiol crosslinker was added to the
PEG-MAL and peptide solution in order to initiate gelation
through a second maleimide-thiol Michael-type addition
reaction (Figure 2, Supplemental Figure 1). Gel solution
was pipetted into chamber slides (Nunc Lab-Tek Chamber
Slide Systems™, ThermoFisher Scientific, Waltham, MA)
or well plates as needed for subsequent assays. Gels were
neutralized in 1X PBS pH 7.4 and allowed to swell overnight at 4°C before use for experimentation.
Hydrogels Functionalized with LM-111 4% PEG gels presenting full-length laminin (LM-111) were prepared as
previously described (Supplemental Figure 1).45,54,59
PEGylated laminin (PEGLM) was formed by reacting
Acrylate-PEG-hydroxysuccinimide (Ac-PEG-NHS, 10 kDa,
Creative PEGWorks; Winston-Salem, NC) with laminin-111
(Trevigen; Gaithersburg, MD). Unreacted Ac-PEG-NHS was
removed by dialyzing the PEGLM solution against PBS. The
concentration of PEGLM was determined via 280 nm absorbance and then diluted in 1X PBS (pH 7.4) to 0.5 mg/ml and
allowed to react with 8-arm PEG-Ac (4% w/v; 10 kDa;
Creative PEGworks) and 10% (v/v) Irgacure 2959 (BASF,
Ludwigshafen, Germany). Polymerization occurred upon
exposure to UV light and gels were allowed to swell overnight in 1X PBS pH 7.4. Material characterization of both the
PEG-peptide and PEGLM gels has been previously reported
and the hydrogel stiffness has been shown to be a function of
PEG incorporation rather than ligand density.45,54,59 15% PEG
gels have been shown to produce gels with a bulk substrate
stiffness of 10.5 kPa,54 while 4% PEG creates a hydrogel of
0.3–0.6 kPa.54,59

Characterization of NP attachment to
hydrogels
Percent Cell Attachment 20,000 cells were seeded on
hydrogels (LMP or PEGLM) or untreated chamber slides
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Figure 2. Schematic demonstrating gel formation and subsequent experimentation. PEG hydrogels can be functionalized with an
integrin-binding peptide (red) and/or a syndecan-binding peptide (blue) using maleimide-thiol based Michael-type addition reactions.
Image created with BioRender.com.

(negative control) and allowed to attach for 24 h. The cells
were then fixed in 4% paraformaldehyde (PFA, 10 min),
permeabilized with Triton-X (0.2% diluted in PBS+/+,
10 min), and blocked with 3.75% bovine serum albumin
and 5% nonimmune goat serum for 30 min. Samples were
then stained with phalloidin (1:200, Alexa Fluor-488,
Invitrogen, Carlsbad, CA) to visualize the actin cytoskeleton; nuclei were counterstained with DAPI (2 µg/mL,
Sigma Aldrich, St. Louis, MO). For each sample, a minimum of five regions of interest (ROI) were imaged across
the gel using confocal microscopy (TCS-SPE with DM6
RGBV confocal microscope; Leica DFC7000T camera;
using Leica LAS X core software; Leica Microsystems,
Wetzlar, Germany).
Nuclei were counted in the ROIs and total cell attachment was calculated by extrapolating the cell number
determined from the ROIs to the full area of the gel.
Percent cell attachment was calculated as 100*(calculated
cell attachment number/seeded cell number) that is,
100*(the extrapolated value/20,000 cells).
Cell Morphology From the imaged ROIs, cell morphology was categorized as single cells, small clusters (2–3
cells) or large cell clusters (4+ cells).44 Fiji software72 was
used to quantify circularity and spread area for cells attaching as single cells or clusters.
Statistical Analysis of cell attachment and cell morphology Assays to measure cell attachment and morphology were performed for each of three separate human
tissue samples (biological replicates) per hydrogel condition and a minimum of 70 cells were visualized per human
subject. In order to test for differences in percent cell
attachment and cell morphology amongst the single-peptide gels (YIGSR, P4, A5G81, GD-6, IKVAV, and AG73),
one-way ANOVAs (factor (1) = peptide, levels (6) = peptide sequence) were performed with Tukey’s multiple
comparisons tests with repeated measures. Additionally, in
order to compare the effects of the LMP gels to biomaterials presenting the full-length laminin, repeated measures
one-way ANOVAs with a Dunnett’s multiple comparison

were used to test patient-matched data for differences in
cell behaviors on the single-peptide gels compared to that
observed on 4% PEGLM. Two-tailed t-tests were used to
compare cell behavior metrics on gels with dual presentation of LMPs (ex. YIGSR + AG73) to gels functionalized
with a single LMP (ex. YIGSR alone or AG73 alone).
Quantifying Effect of Integrin Blocking on Cell
Attachment In order to assess the integrin subunits that
mediate NP cell attachment to LMPs, integrin blocking
was performed. Cells were serum-starved overnight before
use for this assay. After being trypsinized and neutralized
in trypsin soybean inhibitor, cells (10,000 cells per well)
were incubated with integrin blocking or isotype control
antibodies (1:50) for 30 min at 37°C before seeding on
LMP gels in chamber slides (Table 1). After 2 h, cell attachment was quantified using the CellTiter-Glo (Promega,
Madison, WI) assay according to manufacturer’s protocol
and previous studies.40,54,58 Relative attachment to LMP
gels was calculated as 100*(cell attachment in samples
treated with integrin blocking antibodies/samples treated
with IgG control antibody). A total of six technical replicates were quantified for each condition from three biological replicates. One-tailed paired t-tests were used to
test for reductions in cell attachment between integrin
blocked- and IgG-treated samples.

Quantifying protein phosphorylation
Bioactivity of the gels was assessed by measuring phosphorylation of ERK 1/2 and GSK3β using AlphaLISA kits
(PerkinElmer, Waltham, MA) per the manufacturer’s protocol with the following modifications. Serum-starved NP
cells were seeded on LMP or PEGLM gels (10,000 cells
per gel in 96 1/2 area well) and cultured at 37°C for 15 min
(ERK 1/2) or 120 min (GSK3β). These timings were determined based on preliminary experiments (data not shown)
and are consistent with previous protocols.58,73–75 After the
appropriate culture time, the media was gently aspirated
from the wells containing the gels and the lysis buffer was
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Table 1. Primary antibodies utilized for immunocytochemistry and integrin blocking.
Antibodies for Immunocytochemistry
Target

Species; Dilution

Manufacturer

YAP
Paxillin

Mouse; 1:100
Rabbit; 1:100

Santa Cruz Biotechnology
Abcam

Antibodies for live-cell integrin blocking (azide-free, 20 µg/mL)
Integrin

Anti-integrin antibody

Control IgG antibody

α3

Clone P1B5 (MilliporeSigma)

Mouse IgG1 (ThermoFisher Scientific)

Abcam, Cambridge, UK; MilliporeSigma, St. Louis, MO; Santa Cruz Biotechnology, Dallas, TX; Thermo Fisher Scientific, Waltham, MA.

Table 2. Primers for qRT-PCR.
Gene

Common name

Product number
(applied biosystems)

ACAN
CDH2
SLC2A1 (GLUT1)
COL2A1
COL1A1
GAPDH
18S

Aggrecan
N-Cadherin
Glucose transporter 1
Collagen type II
Collagen type I
Glyceraldehyde 3-phosphate dehydrogenase (Housekeeping Gene)
18S Ribosomal RNA (Housekeeping Gene)

Hs00153936_m1
Hs00983056_m1
Hs00892681_m1
Hs00156568_m1
Hs00164004_m1
4332649
Hs99999901_s1

applied for 10 min to lyse adherent cells. The solution was
then transferred to empty wells into which the acceptor
and donor buffers were subsequently added; this was done
in order to avoid interference from the gel. Six technical
replicates were quantified for each gel and protein (ERK
1/2 and GSK3β) from three biological replicates. One-way
ANOVAs were performed to test for differences in protein
phosphorylation amongst single-peptide gels (Tukey’s
multiple comparisons test) or compared to PEGLM
(Dunnett’s multiple comparison test).

to visualize the gene expression data from the LMP gels
compared to the full-length protein, gene expression for
cells cultured on 4% PEGLM was also quantified (using
the same ∆∆Ct method – normalized first to housekeeping
genes and then to the AG73-functionalized gels). Gene
expression was quantified for each condition as obtained
from 3 to 5 biological replicates. Radar plots were generated using LiveGap Charts (https://charts.livegap.com) in
order to visualize patterns in gene expression between substrate conditions.

Characterization of gene expression of
phenotypic markers

Characterization of protein expression and
nascent protein production

RT-qPCR was conducted to assess expression of genes
characteristic of juvenile NP cells.28 A total of 300,000
cells were seeded on each gel condition. After 4 d of culture on 15% PEG LMP-functionalized or 4% PEGLM
gels, RNA was extracted, reverse transcribed to cDNA,
and qPCR was performed to quantify expression of ACAN,
CDH2, GLUT1, COL2A1, and COL1A1 (Table 2). The
∆∆Ct method was used to compare expression of phenotype markers first to the housekeeping genes 18S and
GAPDH and then to cells cultured on AG73-functionalized
gels. This analysis allowed for the comparison of single
integrin-binding LMP gels to the syndecan-binding gel
and also allowed dual peptide gels to be compared to single peptide gels. To provide a reference by which

Further characterization of protein expression on a subset
of gels was utilized to confirm that the LMPs are able to
support focal adhesion formation, biosynthesis, and intracellular signaling through an additional mechanotransducive pathway (YAP/TAZ). Expanded descriptions of
immunolabeling processes are described below. Briefly,
following 4 d of cell culture on A5G81- or IKVAVfunctionalized gels (10,000 cells per gel in an 8-well
chamber slide), cells were fixed using 4% PFA, permeabilized, and immunolabeled as described below with nuclei
counterstained using DAPI. An average of 5 ROIs were
imaged for each gel and each human subject such that a
minimum of 35 cells were quantified for each protein
respectively as obtained from three biological replicates.

6
Two-tailed t-tests were performed to assess whether differences in these cell behaviors were observed between the
two gel conditions.
Quantification of Focal Adhesions To assess the cellgel interactions, cells on A5G81 or IKVAV gels were
stained using anti-paxillin antibodies or respective isotype controls (Table 1) and an Alexa Fluor secondary
antibody (1:200). The samples were imaged as previously described and quantification of focal adhesion area
was performed in Fiji software according to previously
reported protocols.54,72,76
Quantification of YAP Localization Cells on IKVAV or
A5G81 gels were stained using a mouse anti-YAP primary
antibody (1:100; Table 1) or respective isotype controls
and an Alexa Fluor secondary antibody (1:200). Sample
ROIs were then imaged as previously described. Nuclear
and cytoplasmic localization was quantified in Fiji by
measuring expression of YAP in regions with DAPI staining (nuclear YAP) and in the extra-nuclear space of the cell
body (cytoplasmic YAP). YAP signal was reported as the
ratio of nuclear to cytoplasmic protein expression.54,59
Characterization of Biosynthesis Additionally, the biosynthetic capacities of cells cultured on the A5G81 or
IKVAV gels were quantified. Fluorescence non-canonical
amino acid tagging (FUNCAT) imaging was used to quantify intracellular biosynthesis and extracellular protein
deposition as previously described.77–79 Briefly, two media
solutions were prepared for use in cell culture – DMEM
(without HEPES, sodium pyruvate, L-methionine,
L-cysteine, or L-glutamine) was supplemented with 10%
FBS, ascorbic acid (Sigma Aldrich), sodium pyruvate
(Thermo Fisher Scientific), glutamax (1:100, Thermo
Fisher Scientific), 1% penicillin/streptomycin, L-cysteine
(Sigma Aldrich), and either L-methionine (control media,
Sigma Aldrich) or AHA (L-azidohomoalanine, an analog
for L-methionine used for the labeling media, Click
Chemistry Tools; Scottsdale, AZ). Cells (10,000 cells per
gel in an 8-well chamber slide) were seeded on IKVAV- or
A5G81-functionalized gels and cultured for 4 d in the
media that containing either the amino acid methionine or
the methionine analog (AHA). After this culture period,
the media was removed and the samples were incubated
for 40 min (37°C, 5% CO2) with DBCO-488 (5 mM
DBCO-488 diluted 1:165 in PBS with 1% BSA; Click
Chemistry Tools) to label the proteins which incorporated
AHA. The samples were then washed, fixed with 4% PFA
(10 min), permeabilized in 0.2% Triton-X (10 min),
and stained with AlexaFluor phalloidin-633 and DAPI
(2 µg/mL) to visualize cytoskeleton and nuclei, respectively. The samples were imaged as previously described
for immunostaining (SPE DM6 Leica confocal microscopy) in order to obtain 2D confocal images. Nascent
intracellular protein biosynthesis was assessed by quantifying the mean fluorescence intensity of the DBCO channel in the region within the cell body (as determined by
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co-localization with the phalloidin stain) and extracellular
protein deposition was quantified by examining the fluorescence located outside of the cell body.

Dimensionality reduction
As previously described, cell behaviors were characterized
on the LMP gels through multiple measures of NP cell
phenotype. It is not well understood how distinct types of
NP cell responses contribute to the overall NP cell phenotype. Therefore, analysis was performed to distill the
multi-dimensional data presented in order to better understand the interplay between cell behaviors and the cues
provided by the LMP gels. A data matrix was made representing the average value of the results of those cell behavior metrics which were assessed on all gel conditions (cell
attachment, spread area of single cells, spread area of clustered cells, % of cells clustered, circularity of single cells,
cell attachment following integrin α3 blocking, and gene
expression (ACAN, CDH2, GLUT1, COL2A1, and
COL1A1) from biological replicates obtained from three
human patients.
Using this data matrix, correlation analysis was calculated in Prism GraphPad (v9 San Diego, CA). A correlation matrix (of correlation coefficient, r, values) was
produced within the software as the result of pairwise linear correlations calculated between each of the metrics in
order to determine cell behaviors which might be co-regulated in NP cells. Principal components analysis (PCA)
was also performed in Prism GraphPad. In order to eliminate variability introduced by simultaneous study of variables with distinct ranges of values, the data were scaled
for a mean of zero and a standard deviation of 1 for each
variable. PCA was performed on this scaled data matrix
and the eigenvalues were used to identify the variance captured by each principal component (PC). Furthermore, the
PC scores were used to identify the clustering of LMP gel
conditions, and the loadings provided insight into the relative contributions of measured cell behavior metrics to the
variance captured in both PC 1 and 2.
Additionally, “leave one out” validation was performed
within Prism GraphPad using the following method in
order to identify the relative ability of a cell behavior to
predict a given gene’s expression. First, a training set was
constructed from the data collected on single peptide gels
or PEGLM (cell behaviors = cell attachment, single cell
area, large cluster area, % clustered, circularity, and attachment following integrin α3 blocking). Next, a single metric (ex. cell attachment) was removed from the training set
and Principal Components Regression was performed (in
Prism GraphPad) in order to predict the results of gene
expression. R2 values were calculated as a metric of goodness of fit of the predicted gene expression values compared to the known gene expression; the removed data
were then replaced in the training matrix and the process
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Figure 3. Stiff gels (15% PEG) functionalized with laminin-mimetic peptides promote cell attachment and morphologies similar
to those seen in cells in culture on 4% PEGLM: (a) total cell attachment to the LMP gels after 24 h. Percentage of cells that were
adherent as (b) single cells or (c) large cell clusters (4+ cells). Spread area for (d) single cells or (e) large clusters. (f) Circularity of
single cells.
For all plots: data represents samples as obtained from three human subjects.
bars: mean ± standard deviation; gray dotted line: average value on 4% PEGLM; gray solid line: average value on glass.
Comparing amongst single peptides: *p < 0.05, #p < 0.09; comparing to PEGLM: ^p < 0.05 and &p < 0.09.

was repeated for all six-cell behavior metrics of the training data.

Results
Laminin-mimetic peptide-functionalized gels
promote NP cell attachment and rounded,
clustered morphologies similar to PEGLM
NP cells attached to 15% LMP gels at levels greater than
attachment to uncoated glass when gels were functionalized with one LMP; further cell attachment levels were not
statistically different from 4% PEGLM (p > 0.05 for all
comparisons; Figure 3(a)). Although cell attachment was
similar between most gels functionalized with a single
LMP, differences in cell attachment were observed

between gels functionalized with A5G81 and those presenting AG73 (p = 0.042; Figure 3(a)).
Cell clustering is phenotypic of juvenile NP cells, so we
next sought to explore the relative appearance of single
cells and cell clusters (Supplemental Figure 2). The frequency of single cells and large clusters in adherent cells
on PEGLM resembled those seen on the LMP gels
(p > 0.21; Figure 3(b) and (c)). Furthermore, morphologies were generally similar amongst the LMP gel conditions; only A5G81 and GD-6 showed differences in the
percentage of single cells (p = 0.028; Figure 3(b)) and
fewer large clusters formed on AG73 compared to GD-6
(p = 0.045; Figure 3(c)).
In contrast to degenerative NP cells which become
elongated and demonstrate large cell spread areas, juvenile
NP cells often assume a rounded cell morphology with
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Figure 4. Stiff LMP gels demonstrate similarities in bioactivity but differences in bio-inductive capabilities. Phosphorylation of major
signaling proteins: (a) ERK 1/2 and (b) GSK3β. For (a) and (b) gray dotted line = average value on 4% PEGLM; comparing amongst
single peptides: *p < 0.05. (c) Cell attachment following blocking of integrin α3; relative cell attachment = 100*(integrin-blocked/
IgG control); *p < 0.05 compared to IgG-treated cells. (d) Radar plots depicting average expression for phenotypic markers relative
(relative gene expression = 2−∆∆Ct comparing to housekeeping genes and syndecan-binding peptide AG73); scales adjusted as needed
to show gene expression on LMP gels.
For all plots: data represents samples as obtained from at least three human subjects.
bars: mean ± standard deviation.

relatively small spread areas. Therefore, the cell spread
areas and circularity of cells was also quantified. While
statistically significant differences were seen in cell spread
area for single cells cultured on A5G81, IKVAV, and AG73
compared to PEGLM (p = 0.0018, p = 0.0022, and
p < 0.00010 respectively; Figure 3(d)), all single cells on
LMP gels showed areas that were reduced compared to
cells on glass. Similar single cell areas were observed
amongst most LMP gel conditions (Figure 3(d)), although
single cell areas were larger on AG73 than they were on
GD-6 (p = 0.045) and the difference between P4 and AG73
trended toward significance (p = 0.085). Likewise, the
average size of large cell clusters on LMP gels were more
similar to those on PEGLM than glass (Figure 3(e)). Large
clusters on IKVAV had greater areas than those on PEGLM
(p = 0.0092) and differences in large cluster size between
PEGLM and P4 or AG73 trended toward significance
(p = 0.069 and p = 0.053 respectively). YIGSR promoted
the largest cluster size and showed altered cell cluster size
compared to IKVAV (p = 0.032; Figure 3(f)). Only AG73
demonstrated circularity that differed compared to PEGLM
(p = 0.0082) though circularity also differed between

A5G81 and AG73 (p = 0.017) and trended toward significance for GD-6 and AG73 (p = 0.082). Understanding the
morphological characteristics of cells on these substrates
provides context for how the cells are sensing the underlying biomaterial.

Laminin-mimetic peptides activate
mechanosensitive pathways
Cell attachment, morphology, and spreading are known to
be downstream of cell receptor interactions with extracellular ligands and subsequent activation of cell signaling
pathways. Paxillin-positive focal adhesions were visualized on a subset of LMP gels and were observed to form in
the adherent cells (data for A5G81 and IKVAV shown in
Supplemental Figure 3(a)). Additionally, intracellular
signaling cascades downstream of integrin binding and
focal adhesion formation were shown to be activated by
LMP gels. ERK 1/2 phosphorylation occurred on both 4%
PEGLM and 15% LMP gels and was similar in both systems (Figure 4(a); p > 0.16 for all comparisons); further,
activation of ERK1/2 was similar amongst most LMP gels,
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although IKVAV had increased ERK 1/2 phosphorylation
compared to both YIGSR and GD-6 (p = 0.038 and
p = 0.023 respectively). GSK3β phosphorylation showed
similar trends; LMP gels promoted similar protein phosphorylation as PEGLM (Figure 4(b); p > 0.62 for all comparisons) and only differences between P4 and A5G81
reached levels of statistical significance (p = 0.022).
Examination of another mechanosensitive pathway, YAP/
TAZ, revealed that YAP was found to be present in both
cytoplasmic and nuclear compartments when cells were
cultured on a subset of LMP gels (IKVAV and A5G81;
Supplemental Figure 3(b)). Additionally, quantification of
nascent protein production in these same representative
gels demonstrated that culture on LMP gels promoted both
intracellular biosynthesis and extracellular protein deposition (Supplemental Figure 3(c)). Together, these findings
provide evidence that the LMPs are bioactive and that cells
cultured on single LMP-functionalized gels are able to signal through similar pathways as they do when they interact
with full-length laminin. Furthermore, inhibition of integrin α3 function reduced cell attachment (p < 0.05) to all
LMP gels (Figure 4(c)). Thus, the activation of these pathways is likely, at least in part, regulated by integrin-mediated mechanisms.

Laminin-mimetic peptides promote differential
expression of markers of juvenile NP phenotype
Five markers of NP phenotype (ACAN, CDH2, GLUT1,
COL1A1, and COL2A1) were quantified in cells cultured
on the hydrogels to screen LMPs for their ability to shift
adult degenerative NP cells toward a juvenile-like state.
Patterns of gene expression differed between integrinbinding and syndecan-binding LMP gels. IKVAV and
GD-6 promoted the greatest expression of all phenotypic
markers (Figure 4(d) left). Expression of COL2A1 and
COL1A1 were highest in GD-6, and IKVAV promoted the
greatest expression of GLUT1, CDH2, and ACAN. YIGSR
and P4 demonstrated intermediate gene expression profiles (Figure 4(d) middle). However, A5G81 promoted
downregulations of the phenotypic markers (Figure 4(d)
right). These findings indicate that amongst the LMPs
tested, IKVAV and GD-6 may have the greatest effect in
promoting the NP cell phenotype.

Principal components analysis (PCA) and
Pearson correlations provide insights on coregulated cell behaviors for NP cells cultured
on gels functionalized with laminin-mimetic
peptides
PCA was conducted to reduce dimensionality of the data
and to identify clustering amongst LMP conditions and
cell behaviors. 75% of total variance was captured by PCs
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1–4; 41% and 17% of the variance were captured by PCs 1
and 2 respectively (Figure 5(a)). Examination of the resultant scores from PCA revealed separation of IKVAV and
GD-6 from the other LMPs by PC1 (Figure 5(b)).
Additionally, to a lesser degree, PC2 was able to separate
PEGLM from the LMPs. The loadings from the PCA demonstrated that gene expression of phenotypic markers
strongly correlated with PC1 and the gene expression metrics clustered together closely in both PC1 and PC2. Single
cell spread area and cell circularity most strongly correlated with PC2, however, these two metrics were negatively correlated with each other (Figure 5(c)).
These trends were further confirmed through the correlation matrix (Figure 5(d)) which demonstrated strong
positive correlations (r > 0.5) amongst the phenotypic
markers, moderate negative correlations between single
cell area and circularity (r = −0.61) as well as cell attachment and single cell area (r = −0.45), and weak correlations
between cell attachment and expression of collagens
(r = −0.35). These findings corroborate that LMP gels
IKVAV and GD-6 were most different from other substrates based on the gene expression profiles they promote
in NP cells. In order to determine the ability of subsets of
the data to predict NP phenotypic markers, “leave one out”
validation was performed in combination with principal
components regression. These data demonstrated that
removing the integrin blocking data reduced the ability to
predict ACAN expression (Supplemental Figure 4).
Further, the ability to predict CDH2, GLUT1, COL2A1,
and COL1A1 expression was reduced upon removal of the
single cell spread area and single cell circularity data
(Supplemental Figure 4). These findings suggest that
ACAN expression may be most strongly related to integrin-mediated mechanotransduction, while the other markers tested may be more strongly regulated by cell shape
and cellular contractility.

Dual presentation of integrin-binding and
syndecan-binding peptides promote similar
morphologies as gels functionalized with a
single peptides
Having characterized gels functionalized with a single
integrin-binding or syndecan-binding peptide, next gels
were formulated to present both an integrin-binding peptide and the syndecan-binding peptide AG73 (dual peptide
gels). Dual peptide gels demonstrated patterns of cell
attachment that largely replicated those seen for the gels
functionalized with a single integrin-binding or syndecanbinding peptide (Figure 6(a)) and showed patterns of
attachment that were between those seen on glass and
PEGLM. Differences in cell attachment between single
and dual peptides was only observed for the
integrin-binding peptide GD-6; co-presentation of GD-6
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Figure 5. Principal components analysis (PCA) and Pearson correlations were utilized to reduce dimensionality and observe
co-regulated behaviors for single peptide gels: (a) percent of variance explained by each PC (black dots) and cumulative variance
(gray bars), (b) PC Scores shows clustering by LMP; peptides were color coded, size of dot indicates syndecan-binding LMP (largest
dot), integrin-binding LMP (medium dot), or full-length protein (smallest dot), (c) loadings show correlations between cell behavior
metrics, and (d) Pearson correlation matrix (r values shown with the color map).

and AG73 demonstrated increased cell attachment compared to GD-6 alone (p = 0.028), but not to AG73 alone
(p = 0.13).
The morphology of attached cells to dual peptide gels
was quantified and compared to gels functionalized with a
single LMP. Dual presentation of YIGSR and AG73 or P4
and AG73 increased single cell attachment compared to
YIGSR (p = 0.063) or P4 (p = 0.0025) alone (Figure 6(b),
Supplemental Figure 2). In contrast, all dual peptide conditions promoted attachment of single cells at levels similar
to AG73 alone (p > 0.26; Figure 6(b)). For all dual peptide
gels, single cell attachment was greater than PEGLM and
below glass (Figure 6(b)). Attachment as large clusters
(4+ cells) to dual peptide gels was reduced for P4 and
AG73 (p = 0.0170) and for A5G81 and AG73 (p = 0.044),
compared to the respective single integrin-binding peptide
(Figure 7(a)). However, only IKVAV + AG73 showed

differential large cell cluster formation compared to AG73
alone (p = 0.0065; Figure 7(a)). Large cell cluster formation was most similar to PEGLM for dual peptide gels that
contained IKVAV and AG73 or GD-6 and AG73.
We next quantified the cell spread areas for the single
cells or large cell clusters. Spread area for single cells was
increased for all dual peptide conditions compared to
AG73 alone (p < 0.062 for all comparisons; Figure 6(c)),
however, compared to gels functionalized with a single
integrin-binding peptide, only GD-6 + AG73 showed different single cell spread area (p = 0.059). Large cell cluster
area was decreased on dual peptide gels compared to both
single peptide gels for YIGSR (p = 0.058 compared to
AG73 alone, p = 0.015 compared to YIGSR alone, Figure
7(b)). Cells cultured on gels functionalized with P4 and
AG73 had similar cell areas compared to gels which presented P4 only (p = 0.17), but reduced cell cluster area
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Figure 6. Characterization of PEG gels with integrin-binding and syndecan-binding peptides and single cell behaviors: (a) total cell
attachment for cells seeded on single or dual peptide gels, (b) cell attachment to single or dual peptide gels as single cells, (c) cell
spread area for single cells, (d) single cell circularity.
For all plots: data obtained from at least three human subjects.
bars: mean ± standard deviation; dotted line: average value on 4% PEGLM; solid line: average value on glass.
t-Tests comparing integrin binding peptide to dual peptide gels: *p < 0.05, **p < 0.01, ***p < 0.001, #p < 0.09; comparing dual peptide gels to
syndecan-binding peptide: %p < 0.05, χp < 0.09.

compared to the AG73 gels (p = 0.029). Additionally, gels
with IKVAV + AG73 had increased cell areas compared to
IKVAV (p = 0.010) but not AG73 (p = 0.20). For both single cells and clusters adherent to dual peptide gels, spread
cell areas were observed to be between the size of cells/
clusters on soft PEGLM and glass.
All single cells on LMP gels assumed a geometry that
was generally round (circularity > 0.7), though several statistically significant differences were observed as a function of LMP presentation (Figure 6(d)). Functionalization
of gels with both integrin and syndecan binding peptides
promoted significantly reduced cell circularity for A5G81
(p = 0.0001) compared to the gel condition with A5G81
alone. Additionally, gels presenting YIGSR + AG73 and
GD-6 + AG73 promoted increased cell circularities compared to gels with only the syndecan binding peptide AG73
(p = 0.08 and p = 0.037).

Gene expression of phenotypic markers was generally
highest on gels functionalized with a single integrin-binding peptide (Figure 7(c)). For example, expression of
COL1A1, COL2A1, and GLUT1 was highest on YIGSR
gels compared to AG73, YIGSR + AG73, or PEGLM
gels. Expression of ACAN was similar between YIGSR +
AG73, PEGLM, and AG73 gels, and higher on these gels
than on gels functionalized with YIGSR alone. In contrast,
CDH2 expression was similar between AG73, YIGSR,
and PEGLM gels and lowest on YIGSR + AG73.
Dimensionality reduction of dual and single peptide
data together demonstrated that PC1 and PC2 accounted
for 39% and 16% of total variance respectively (Figure
8(a)). As with the single peptide data (Figure 5), it was
observed that IKVAV and GD-6 (without AG73) both separated from the rest of the data along PC1 (Figure 8(b)).
Neither PC1 nor PC2 was able to separate the other single
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Figure 7. Characterization of PEG gels with integrin-binding and syndecan-binding peptides on the behavior of cells in large
clusters and gene expression profiles: (a) attachment to gels as large clusters, (b) quantification of spread area for large cell clusters,
(c) radar plots of relative gene expression for NP phenotypic markers for cells cultured on single peptide gels, dual peptide gels, or
PEGLM (relative gene expression = 2−∆∆Ct comparing to housekeeping genes and syndecan-binding peptide AG73); scales adjusted to
capture the respective data on a single axis.
For all plots: data from at least three human subjects.
bars: mean ± standard deviation; dotted line: average value on 4% PEGLM; solid line: average value on glass.
t-Tests comparing integrin binding peptide to dual peptide gels: *p < 0.05; comparing dual peptide gels to syndecan-binding peptide: %p < 0.05, χp < 0.09.

and dual LMP conditions. Gene expression for CDH2,
GLUT1, COL2A1, and COL1A1 showed strong correlations with PC1 (Figure 8(c)); whereas percentage of clustered cells was the most strongly correlated to PC2 (Figure
8(c)). The correlation matrix confirmed that while most
genes were associated, only weak correlations were seen
between ACAN and COL2A1 and COL1A1 (Figure 8(d)).
The data from both single and dual peptide gels also demonstrated negative correlations between cell circularity

and cell area, corroborating that a greater degree of circularity (rounder cells) is associated with decreased cell
spread areas.

Discussion
Data from the present study demonstrate the ability of an
array of LMPs conjugated to a 15% PEG biomaterial system to regulate NP cell behaviors in a manner similar to
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Figure 8. Principal components analysis (PCA) and Pearson correlations were utilized to reduce dimensionality and observe
co-regulated behaviors for single and dual peptide gels: (a) percent of variance explained by each PC (black dots) and cumulative
variance (gray bars), (b) PC Scores shows clustering by LMP; peptides were color coded, size of dot indicates full-length protein
(smallest dot), single LMP peptide (medium sized dots), dual LMP peptide (largest dot), (c) Loadings show correlations between cell
behavior metrics, and (d) Pearson correlation matrix (r values shown with the color map).

4% PEGLM. The use of peptides offers advantages over
full-length proteins in both economic value and ligand
specificity. Furthermore, this polymer system is able to
rapidly crosslink in situ while retaining the ability to
encapsulate and deliver cells to an IVD defect.80 Herein we
have screened these peptides for their ability to regulate
NP cell attachment, morphology, and phenotype, confirmed the bioactivity of the LMPs, and have identified
cell receptors that facilitate mechanotransduction between
the cells and the biomaterials (Table 3). Additionally, we
have shown that integrin-mediated mechanisms may be
most able to de-differentiate degenerative human NP cells
toward a juvenile-like state.
Previous studies have identified the ability for LMPs to
modulate cell behaviors in peptide sequence- and cell sourcedependent manners. Data from the present study similarly
demonstrated that NP cell attachment and morphology metrics such as cell spread area and circularity showed variability amongst the peptide-conjugated hydrogels. Notably, stiff

gels functionalized with 100 µM of a single LMP promoted
behaviors that generally resembled those of cells on soft gels
functionalized with full-length LM-111 and corroborate
prior findings of studies which have conjugated LMPs to
additional polymeric backbones including polyacrylamide40
and alginate (unpublished data). This is likely in part associated with the observation that interactions between NP cells
and the LMP-functionalized gel activated mechanosensitive
pathways ERK 1/2 and GSK3β at levels comparable to that
seen in soft PEGLM. Engagement of these pathways is
known to contribute to regulation of gene expression,81,82
focal adhesion formation,83 and cytoskeletal remodeling84–86
at early time points, all of which ultimately result in cell
viability,83–85,87 cell cycle progression,85,88 and motility.84
Additionally, these cellular processes modulate cell differentiation or phenotype.84,89 Prior research has demonstrated
that gene expression of NP cell markers can be regulated
through microenvironmental conditions such as substrate
stiffness, ligand presentation and density, and cell shape as

Table 3. Summary of cell behaviors induced by gels functionalized with an integrin binding peptide without (-) or with (+) co-presentation of the syndecan binding peptide AG73.
The colormap indicates ranking from the lowest value (purple) to greatest value (yellow)
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Figure 9. NP cell morphology, biosynthesis, and phenotype
can be modulated through biomaterials which present fulllength laminins or LMPs that promote intracellular signaling
and development of cell-cell and cell-matrix interactions. Figure
created with BioRender.com.

well as relative contributions of cell-cell and cell-matrix
interactions (Figure 9).59,70,90–92 Statistical modeling in the
present study corroborates these findings and further suggests that engagement of integrin α3 may specifically promote ACAN expression, while CDH2, GLUT1, COL2A1,
and COL1A1 transcription may be promoted by processes
further downstream of integrin activation including cell
shape and cytoskeletal regulation. Despite all the singleLMP gels promoting protein phosphorylation at levels comparable to the full-length laminin, differences were observed
between peptides and the full protein for expression of the
phenotypic markers. Gene expression of phenotypic markers
was greatest on the gels functionalized with IKVAV (maximum expression for ACAN, CDH2, and GLUT1) and GD-6
(maximum expression for COL2A1 and COL1A1) and the
lowest expression of phenotypic markers was seen on the
A5G81 gels. This finding indicates that specific LMPs may
be particularly well-suited to drive biosynthetic activity in
NP cells.
Having characterized biomaterials functionalized with a
single LMP, gels were next made that presented an integrinbinding LMP in combination with the syndecan-binding
LMP, AG73. Prior reports have indicated a synergistic
interaction between integrins and syndecans93–96 in driving
cell attachment and intracellular signaling. Thus, a hypothesis for the present study was that dual presentation of an
integrin-binding peptide with AG73 would promote
increased NP cell attachment and expression of phenotypic
markers as compared to single peptide presentation alone.
The metrics for cell attachment, cell/cluster morphology,
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and gene expression generally demonstrated that stiff gels
functionalized with 100 µM of total LMP were able to promote similar behaviors as the soft PEGLM. However, when
comparing between the single and dual peptide gels, the
presence of AG73 tended to be antagonistic to the effects
observed for the integrin-mediated modulation of NP cell
behavior on dual peptide-functionalized hydrogels. For
example, gene expression of NP markers was generally
greatest on the single peptide gel, and lowest on the duallyfunctionalized hydrogel. This effect may be in part due to
syndecan phosphorylation resulting in integrin endocytosis
and trafficking away from the membrane and thereby
altered integrin expression and a decreased ability to interact with the integrin-binding LMPs in the gel, as has been
reported in prior studies.93,95,97–99 Future experimentation
would be needed to characterize the kinetics of expression
of adhesive proteins, focal adhesion turnover, and intracellular signaling in order to elucidate the relative roles of
integrins and syndecans in mediating degenerative NP cells
interactions with the extracellular environment.86,93,95,99–101
While the dual presentation of integrin-binding and
syndecan-binding peptides did not elicit a synergistic
response in the present study, combinations of other peptides may have the beneficial effects not specifically
observed here.102 For example, combining IKVAV and
GD-6 which each promoted the greatest expression of different phenotypic markers may result in an additive or
synergistic effect and warrants future study. While we
examined a subset of integrin-binding LMPs, the fulllength laminin protein contains many other integrin-binding peptides which have not yet been screened for use in
NP cell culture. Further characterization of the LMP conditions used herein (or the introduction of other LMPs)
should expand on the results of the present study to
include the quantification of a broad range of phenotypic
markers at the protein level and the results of focal adhesion formation, nascent protein production, and YAP
localization that were quantified for A5G81- or IKVAVfunctionalized gels should be expanded to include all gel
conditions. Another limitation of the present study was
the use of 2D culture; additional experimentation will be
needed to explore the integrin and syndecan mediated
mechanisms in 3D and under physiologic mechanical
loading conditions. Lastly, here only degenerative cells
were used, however, characterizing juvenile NP cell interactions with LMP gels may demonstrate differences in
mechanotransduction between healthy and pathological
samples.
Overall the data presented demonstrate characterization
of a library of bioactive materials that present either a single LMP or a combination of an integrin- and syndecanbinding peptide on a PEG-hydrogel platform. The results
from assessments of cell attachment, morphology, and
phenotypic measures validate the ability of this engineered
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biomaterial constructed from 15% PEG to recapitulate
behaviors elicited by soft gels prepared from 4% PEG and
functionalized with full-length proteins. Use of a 15%
PEG hydrogel platform, with a measured compressive
stiffness of 10.5 kPa and rapid gelation time (~10 min), has
demonstrated success with regulating the NP cell phenotype and global transcriptome54,103 and can be injected into
an IVD defect.80 These findings are clinically relevant as
stiffer, injectable and in situ crosslinking biomaterials have
advantages as a vehicle to deliver cells in a regenerative
engineering strategy to the degenerative disc space.
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